Neoadjuvant anlotinib combined with penpulimab for resectable locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II trial.

被引：0
|
作者：
Chen, Yueyun
Ding, Zhen-Yu
Yuan, Yong
Yang, Yu-Shang
Lin, Zhen
Tian, Jiangfang
Liu, Ting
Yue, Zheng
Shi, Hua-Shan
Hu, Yang
机构：
[1] Sichuan Univ, West China Hosp, Canc Ctr, Dept Biotherapy, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Thorac Surg, Chengdu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
283-424-6846-271-2644; 261-492-5651-2790; 613-4678-146; 613-135-244-3829; 281-318-430; 261-492-2769; 261-566-148-2649; 6; 4; 3; 2; 3342; 2414; 38092-34417; 1;
D O I：
10.1200/JCO.2024.42.3_suppl.352
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：352 / 352
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant anlotinib combined with penpulimab for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Updated data from a prospective, phase II trial
    Chen, Yueyun
    Yuan, Yong
    Yang, Yu-Shang
    Lin, Zhen
    Tian, Jiangfang
    Liu, Ting
    Yue, Zheng
    Shi, Hua-Shan
    Hu, Yang
    Ding, Zhen-Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (ESCC): A single-arm, phase II trial
    Gong, Lei
    Yang, Yueyang
    Zhang, Hongdian
    Qiao, Yufeng
    Wang, Haitong
    Ren, Peng
    Tang, Peng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Neoadjuvant tislelizumab combined with chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Single arm phase II study
    Jin, Peng
    Gao, Yong Sheng
    Fu, Zheng
    Yang, Wen Feng
    Meng, Xue
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Anlotinib combined with penpulimab and nab-paclitaxel as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase II clinical trial.
    Chang, Zhiwei
    Wang, Rui-Rui
    Liu, Xiao-Lei
    Yu, Dan-Dan
    Han, Hui-Qiong
    He, Jian
    Qin, Yanru
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 367 - 367
  • [5] Anlotinib combined with nab-paclitaxel and cisplatin as neoadjuvant treatment for esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase II clinical trial.
    Zhang, Yan-Feng
    Hao, An-Lin
    Hong, Yong-Gui
    Li, Xiao-Ming
    Liang, Wei-Min
    Zheng, Zhi-Xin
    Yang, Guang-Yi
    Guo, Xiao-Feng
    Wen, Yan-Yan
    Cao, Heng
    Le, Cheng
    Song, Hua-Jie
    Su, Wen-Zhong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16015 - E16015
  • [6] Envafolimab plus chemotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II study
    Zhao, Jinbo
    Yan, Xiaolong
    Bai, Yuquan
    Duan, Hongtao
    Jiang, Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Update results of anlotinib combined with penpulimab and nab-paclitaxel as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase II clinical trial.
    Chang, Zhiwei
    Liu, Xiao-Lei
    Yu, Dan-Dan
    Han, Hui-Qiong
    He, Jian
    Wang, Rui-Rui
    Jia, Yong-Xu
    Yan, Jie
    Qin, Yanru
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial)
    Huang, Yingying
    Sun, Jingjing
    Li, Jun
    Zhu, Dongwang
    Dong, Minjun
    Dou, Shengjin
    Tang, Yong
    Shi, Wentao
    Sun, Qi
    Zhao, Tongchao
    Zhou, Zhihang
    Zhou, Xinyu
    Liu, Ying
    Li, Jiang
    Zhu, Guopei
    Zhang, Ding
    Chen, Yanan
    Zhu, Qi
    Ju, Wutong
    Zhong, Laiping
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (08) : 2220 - 2227
  • [9] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Yang, Guozhen
    Su, Xiaodong
    Huang, Yuanheng
    Luo, Guangyu
    Wang, Zhiqiang
    Cai, Peiqiang
    Zheng, Yating
    Bei, Ting
    Huang, Mengli
    Bai, Yuezong
    He, Haoqiang
    Xiang, Jin
    Cai, Muyan
    Zhong, Jiudi
    Guo, Qiyu
    Zhang, Xu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [10] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Guozhen Yang
    Xiaodong Su
    Yuanheng Huang
    Guangyu Luo
    Zhiqiang Wang
    Peiqiang Cai
    Yating Zheng
    Ting Bei
    Mengli Huang
    Yuezong Bai
    Haoqiang He
    Jin Xiang
    Muyan Cai
    Jiudi Zhong
    Qiyu Guo
    Xu Zhang
    Journal of Translational Medicine, 21
12345